The effect of commercial thermogenic weight loss supplement on body composition and energy expenditure in obese adults

Journal of Exercise Physiology Online

Volumn 4, Issue 2, 2001, Pages 28-34

  Armstrong, W Jeffrey ^a   Johnson, Patrick ^a   Duhme, Simone ^a  

^a EASTERN MICHIGAN UNIVERSITY   (United States)

Author keywords

Cholesterol; Dexa; Energy Expenditure; Ephedrine; Exercise; Glucose; Ma Huang; Triglycerides; Weight Loss

Indexed keywords

CAFFEINE; CHOLESTEROL; EPHEDRINE; GLUCOSE; HERBACEOUS AGENT; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; APPETITE; ARTICLE; BODY COMPOSITION; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ENERGY EXPENDITURE; EXERCISE; FAT BODY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LEAN BODY WEIGHT; LIPOPROTEIN BLOOD LEVEL; MALE; OBESITY; REST; SUPPLEMENTATION; THERMOGENESIS; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

EID: 0009670868     PISSN: 10979751     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Astrup A, Soubro S, Cannon S, Hein P, Madsen J. Thermogenic, metabolic, and cardiovascular effects of a sympathomimetic agent, ephedrine. Curr Ther Res 1990;48(6):1087-1100.
2. Blau JJ. Ephedrine nephrolithiasis associated with chronic ephedrine abuse. J Urol 1998;160:825.
3. Breum L, Pedersen JK, Ahlstrøm F, Frimodt-Møller J. Comparison of an ephedrine/caffeine combination and dexfenfluramine in the treatment of obesity. A double-blind multi-centre trial in general practice. Int J Obesity 1994;18:99-103.
4. Cupps MJ. Herbal remedies: adverse effects and drug interactions. Am Fam Physician 1999;59(5):1239-1244.
5. Dalton S. Overweight and weight management: the health professional's guide to understanding and practice. Gaithersburg: Aspen Publishers, Inc., 1997.
6. Daly PA, Krieger DR, Dulloo AG, Young JB, Landsberg L. Ephedrine, caffeine and aspirin: safety and efficacy for treatment of human obesity. Int J Obesity 1993;17(Suppl. 1):S73-S78.
7. Emmanuel NP, Jones C, Lydiard, RB. Use of herbal products and symptoms of bipolar disorder. Am J Psychiatry 1998;155(11):1627.
8. Gurley BJ, Gardner SF, White LM, Wang P-L. Ephedrine pharmokinetics after ingestion of natural supplements containing Ephedra sinica (ma huang). Ther Drug Monit 1998;20:439-445.
9. Jacobs KM, Hirsch KA. Psychiatric complications of ma-huang. Psychosomatics 2000;41(1):58-62.
10. Mazess RB, Barden HS, Bisek JP, Hanson J. Dual-energy x-ray absortiometry for total-body and regional bone mineral and soft-tissue composition. Am J Clin Nutr 1990;51:1106-1112.
11. Pasquali R, Baraldi G, Cesari MP, Melchionda N, Zamboni M, Stefanini C, Raitano A. A controlled trial using ephedrine in treatment of obesity. Int J Obesity 1985;9:93-98.
12. Pierson RN, Wang J, Heymsfield SB, Russell-Aulet M, Mazariegos M, Tierney M, Smith R, Thornton JC, Kehayias J, Weber DA, Dilmanian. Measuring body fat: calibrating the rulers. Intermethod comparisons in 389 normal Caucasian subjects. Am J Physiol 1991;261:E103-E108.
13. Ramsey JJ, Colman RJ, Swick AG, Kemnitz JW. Energy expenditure, body composition, and glucose metabolism in lean and obese rhesus monkeys treated with ephedrine and caffeine. Am J Clin Nutr 1998;68:42-51.
14. Shannon JR, Gottesdiener K, Jordan J, Chen K, Flattery S, Larson PJ, Candelore MR, Gertz B, Robertson D, Sun M. Acute effect of ephedrine on 24-h energy balance. Clin Sci 1999;96:483-491.
15. Spraul M, Ravussin E, Fontvieille AM, Rising R, Larson DE, Anderson EA. Reduced sympathetic nervous system activity. A potential mechanism predisposing to body weight gain. J Clin Invest 1993;92 (4):1730-1735.
16. Toubro S, Astrup A, Breum L, Quaade F. Safety and efficacy of long-term treatment with ephedrine, caffeine and an ephedrine/caffeine mixture. Int J Obesity 1993;17(Suppl. 1):S69-S72.
17. nd ed. Champaign, IL: Human Kinetics, 1999.